|
786-0
|
IC50 |
|
Cytotoxicity against human 786-O cells after 72 hrs by MTT assay
Cytotoxicity against human 786-O cells after 72 hrs by MTT assay
|
[PMID: 19637874]
|
|
A2780
|
IC50 |
|
Cytotoxicity against human A2780 cells assessed as cell viability measured after 48 hrs by MTT assay
Cytotoxicity against human A2780 cells assessed as cell viability measured after 48 hrs by MTT assay
|
[PMID: 38964974]
|
|
A549
|
IC50 |
|
Cytotoxicity against human A549 lung tumor cells
Cytotoxicity against human A549 lung tumor cells
|
[PMID: 16455242]
|
|
A549
|
IC50 |
0.0175 μM
Compound: Triptolide
|
Cytotoxic activity against human A549 cells assessed as reduction in cell viability after 72 hrs by SRB assay
Cytotoxic activity against human A549 cells assessed as reduction in cell viability after 72 hrs by SRB assay
|
[PMID: 28011223]
|
|
A549
|
IC50 |
|
Cytotoxicity against human A549 cells
Cytotoxicity against human A549 cells
|
[PMID: 21470864]
|
|
A549
|
IC50 |
|
Growth inhibition of human A549 cells
Growth inhibition of human A549 cells
|
[PMID: 28814374]
|
|
A549
|
IC50 |
|
Cytotoxicity against human A549 cells after 72 hrs by MTT assay
Cytotoxicity against human A549 cells after 72 hrs by MTT assay
|
[PMID: 19637874]
|
|
A549
|
IC50 |
1.3 ng/mL
Compound: 1a, triptolide
|
Cytotoxicity against human A549 cells
Cytotoxicity against human A549 cells
|
[PMID: 18321701]
|
|
A549
|
IC50 |
|
Antagonist activity at human PAR2 expressed in human A549 cells assessed as inhibition of 2f-LIGRLO-NH2-induced NFkappaB activation by luciferase reporter gene assay
Antagonist activity at human PAR2 expressed in human A549 cells assessed as inhibition of 2f-LIGRLO-NH2-induced NFkappaB activation by luciferase reporter gene assay
|
[PMID: 23895492]
|
|
A549
|
IC50 |
|
Antagonist activity at human PAR2 expressed in human A549 cells coexpressing TACR1 assessed as inhibition of substance P-induced IL-8 production by ELISA
Antagonist activity at human PAR2 expressed in human A549 cells coexpressing TACR1 assessed as inhibition of substance P-induced IL-8 production by ELISA
|
[PMID: 23895492]
|
|
B16-F10
|
IC50 |
|
Antiproliferative activity against human B16-F10 cells assessed as reduction in cell growth incubated for 96 hrs by MTT assay
Antiproliferative activity against human B16-F10 cells assessed as reduction in cell growth incubated for 96 hrs by MTT assay
|
[PMID: 32028140]
|
|
BGC-823
|
IC50 |
|
Antiproliferative activity against human BGC-823 cells assessed as reduction in cell growth incubated for 96 hrs by MTT assay
Antiproliferative activity against human BGC-823 cells assessed as reduction in cell growth incubated for 96 hrs by MTT assay
|
[PMID: 32028140]
|
|
Bel-7402
|
IC50 |
|
Cytotoxicity against human Bel7402 cells after 72 hrs by MTT assay
Cytotoxicity against human Bel7402 cells after 72 hrs by MTT assay
|
[PMID: 19637874]
|
|
DU-145
|
IC50 |
|
Cytotoxicity against human DU145 cells after 72 hrs by MTT assay
Cytotoxicity against human DU145 cells after 72 hrs by MTT assay
|
[PMID: 19637874]
|
|
HCT-116
|
IC50 |
|
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell growth incubated for 96 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell growth incubated for 96 hrs by MTT assay
|
[PMID: 32028140]
|
|
HCT-116
|
IC50 |
|
Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay
|
[PMID: 19637874]
|
|
HCT-116
|
IC50 |
|
Cytotoxicity against human HCT-116 cells incubated for 72 hrs by MTT assay
Cytotoxicity against human HCT-116 cells incubated for 72 hrs by MTT assay
|
[PMID: 35617856]
|
|
HCT-116
|
IC50 |
|
Cytotoxicity against human HCT116 cells assessed as decrease in cell viability
Cytotoxicity against human HCT116 cells assessed as decrease in cell viability
|
[PMID: 31121546]
|
|
HCT-15
|
IC50 |
|
Cytotoxicity against human HCT15 cells after 72 hrs by MTT assay
Cytotoxicity against human HCT15 cells after 72 hrs by MTT assay
|
[PMID: 19637874]
|
|
HT-29
|
IC50 |
|
Cytotoxicity against human HT29 colon tumor cells
Cytotoxicity against human HT29 colon tumor cells
|
[PMID: 16455242]
|
|
HT-29
|
IC50 |
|
Cytotoxicity against human HT-29 cells
Cytotoxicity against human HT-29 cells
|
[PMID: 21470864]
|
|
HT-29
|
IC50 |
|
Cytotoxicity against human HT-29 cells incubated for 72 hrs by MTT assay
Cytotoxicity against human HT-29 cells incubated for 72 hrs by MTT assay
|
[PMID: 35617856]
|
|
HT-29
|
IC50 |
0.1 ng/mL
Compound: 1a, triptolide
|
Cytotoxicity against human HT29 cells
Cytotoxicity against human HT29 cells
|
[PMID: 18321701]
|
|
HUVEC
|
IC50 |
|
Cytotoxicity against HUVEC incubated for 72 hrs by MTT assay
Cytotoxicity against HUVEC incubated for 72 hrs by MTT assay
|
[PMID: 35617856]
|
|
HaCaT
|
IC50 |
|
Cytotoxicity against human HaCaT cells incubated for 72 hrs by MTT assay
Cytotoxicity against human HaCaT cells incubated for 72 hrs by MTT assay
|
[PMID: 35617856]
|
|
HeLa
|
IC50 |
|
Cytotoxicity against human HeLa cells assessed as inhibition of cell proliferation measured after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells assessed as inhibition of cell proliferation measured after 48 hrs by MTT assay
|
[PMID: 34700239]
|
|
HeLa
|
IC50 |
|
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
Cytotoxicity against human HeLa cells after 72 hrs by MTT assay
|
[PMID: 19637874]
|
|
HeLa
|
IC50 |
|
Cytotoxicity against human HeLa cells assessed as decrease in cell viability
Cytotoxicity against human HeLa cells assessed as decrease in cell viability
|
[PMID: 31121546]
|
|
HepG2
|
IC50 |
|
Antiproliferative activity against human HepG2 cells assessed as reduction in cell growth incubated for 96 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as reduction in cell growth incubated for 96 hrs by MTT assay
|
[PMID: 32028140]
|
|
HepG2
|
IC50 |
|
Cytotoxicity against human HepG2 cells assessed as inhibition of cell proliferation measured after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as inhibition of cell proliferation measured after 48 hrs by MTT assay
|
[PMID: 34700239]
|
|
HepG2
|
IC50 |
0.468 μM
Compound: Triptolide
|
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability measured after 48 hrs by CCK-8 assay
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability measured after 48 hrs by CCK-8 assay
|
[PMID: 35476958]
|
|
HepG2
|
IC50 |
|
Cytotoxicity against human HepG2 cells after 48 hrs by XTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by XTT assay
|
[PMID: 30613335]
|
|
Hepatocyte
|
IC50 |
|
Cytotoxicity against primary hepatocytes (unknown origin) after 48 hrs by XTT assay
Cytotoxicity against primary hepatocytes (unknown origin) after 48 hrs by XTT assay
|
[PMID: 30613335]
|
|
Huh-7
|
IC50 |
|
Cytotoxicity against human Huh-7 cells assessed as cell viability measured after 48 hrs by MTT assay
Cytotoxicity against human Huh-7 cells assessed as cell viability measured after 48 hrs by MTT assay
|
[PMID: 38964974]
|
|
Jurkat
|
IC50 |
|
Cytotoxicity against human Jurkat cells assessed as decrease in cell viability
Cytotoxicity against human Jurkat cells assessed as decrease in cell viability
|
[PMID: 31121546]
|
|
K562
|
IC50 |
|
Cytotoxicity against human K562 cells after 72 hrs by MTT assay
Cytotoxicity against human K562 cells after 72 hrs by MTT assay
|
[PMID: 19637874]
|
|
KB
|
ED50 |
2.6 μg/mL
Compound: Triptolide
|
Cytotoxicity against human KB cells
Cytotoxicity against human KB cells
|
[PMID: 7130986]
|
|
KB
|
IC50 |
|
Cytotoxicity against human KB cells after 72 hrs by MTT assay
Cytotoxicity against human KB cells after 72 hrs by MTT assay
|
[PMID: 19637874]
|
|
KBM5
|
IC50 |
|
Cytotoxicity against human KBM5 cells harboring wild type Bcr-Abl after 72 hrs by MTS assay
Cytotoxicity against human KBM5 cells harboring wild type Bcr-Abl after 72 hrs by MTS assay
|
[PMID: 20149665]
|
|
KBM5
|
IC50 |
|
Cytotoxicity against imatinib-resistant human KBM5 cells harboring Bcr-Abl T315I mutant after 72 hrs by MTS assay
Cytotoxicity against imatinib-resistant human KBM5 cells harboring Bcr-Abl T315I mutant after 72 hrs by MTS assay
|
[PMID: 20149665]
|
|
L02
|
IC50 |
|
Cytotoxicity against human L02 cells incubated for 72 hrs by MTT assay
Cytotoxicity against human L02 cells incubated for 72 hrs by MTT assay
|
[PMID: 35617856]
|
|
L02
|
IC50 |
|
Cytotoxicity against human HL7702 cells assessed as inhibition of cell proliferation measured after 48 hrs by MTT assay
Cytotoxicity against human HL7702 cells assessed as inhibition of cell proliferation measured after 48 hrs by MTT assay
|
[PMID: 34700239]
|
|
LNCaP
|
IC50 |
|
Antiproliferative activity against androgen-sensitive human LNCaP cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
Antiproliferative activity against androgen-sensitive human LNCaP cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
|
[PMID: 35247754]
|
|
MCF7
|
IC50 |
|
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 19637874]
|
|
MCF7
|
IC50 |
|
Cytotoxicity against human MCF7 cells assessed as inhibition of cell proliferation measured after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as inhibition of cell proliferation measured after 48 hrs by MTT assay
|
[PMID: 34700239]
|
|
MDA-MB-231
|
IC50 |
|
Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay
|
[PMID: 19637874]
|
|
MDA-MB-231
|
IC50 |
|
Cytotoxicity against human MDA-MB-231 cells incubated for 72 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells incubated for 72 hrs by MTT assay
|
[PMID: 35617856]
|
|
MDA-MB-468
|
IC50 |
|
Cytotoxicity against human MDA-MB-468 cells by SRB assay
Cytotoxicity against human MDA-MB-468 cells by SRB assay
|
[PMID: 19637874]
|
|
MDCK
|
IC50 |
|
Cytotoxicity against MDCK cells assessed as decrease in cell viability
Cytotoxicity against MDCK cells assessed as decrease in cell viability
|
[PMID: 31121546]
|
|
MEF
|
IC50 |
|
Cytotoxicity against MEF after 72 hrs by MTS assay
Cytotoxicity against MEF after 72 hrs by MTS assay
|
[PMID: 20149665]
|
|
MKN-28
|
IC50 |
|
Cytotoxicity against human MKN28 cells after 72 hrs by MTT assay
Cytotoxicity against human MKN28 cells after 72 hrs by MTT assay
|
[PMID: 19637874]
|
|
MOLT-4
|
IC50 |
|
Cytotoxicity against human MOLT4 cells after 72 hrs by MTT assay
Cytotoxicity against human MOLT4 cells after 72 hrs by MTT assay
|
[PMID: 19637874]
|
|
MV4-11
|
IC50 |
|
Antiproliferative activity against human MV4-11 cells assessed as cell growth inhibition measured after 48 hrs by CCK8 assay
Antiproliferative activity against human MV4-11 cells assessed as cell growth inhibition measured after 48 hrs by CCK8 assay
|
[PMID: 36115206]
|
|
NCI-H1299
|
IC50 |
|
Cytotoxicity against human NCI-H1299 cells assessed as inhibition of cell proliferation measured after 48 hrs by MTT assay
Cytotoxicity against human NCI-H1299 cells assessed as inhibition of cell proliferation measured after 48 hrs by MTT assay
|
[PMID: 34700239]
|
|
NCI-H1650
|
IC50 |
|
Antiproliferative activity against human NCI-H1650 cells assessed as reduction in cell growth incubated for 96 hrs by MTT assay
Antiproliferative activity against human NCI-H1650 cells assessed as reduction in cell growth incubated for 96 hrs by MTT assay
|
[PMID: 32028140]
|
|
NCI-H1975
|
IC50 |
|
Cytotoxicity against human NCI-H1975 cells incubated for 72 hrs by MTT assay
Cytotoxicity against human NCI-H1975 cells incubated for 72 hrs by MTT assay
|
[PMID: 35617856]
|
|
NCI-H1975
|
IC50 |
|
Cytotoxicity against human NCI-H1975 cells assessed as inhibition of cell proliferation measured after 48 hrs by MTT assay
Cytotoxicity against human NCI-H1975 cells assessed as inhibition of cell proliferation measured after 48 hrs by MTT assay
|
[PMID: 34700239]
|
|
NCI-H460
|
IC50 |
|
Cytotoxicity against human NCI-H460 cells incubated for 72 hrs by MTT assay
Cytotoxicity against human NCI-H460 cells incubated for 72 hrs by MTT assay
|
[PMID: 35617856]
|
|
NIH3T3
|
IC50 |
|
Cytotoxicity against mouse NIH/3T3 cells assessed as decrease in cell viability
Cytotoxicity against mouse NIH/3T3 cells assessed as decrease in cell viability
|
[PMID: 31121546]
|
|
PANC-1
|
IC50 |
|
Cytotoxicity against human PANC-1 cells assessed as inhibition of cell proliferation measured after 48 hrs by MTT assay
Cytotoxicity against human PANC-1 cells assessed as inhibition of cell proliferation measured after 48 hrs by MTT assay
|
[PMID: 34700239]
|
|
PANC-1
|
IC50 |
|
Cytotoxicity against human Panc-1 cells incubated for 48 hrs by CCK8 assay
Cytotoxicity against human Panc-1 cells incubated for 48 hrs by CCK8 assay
|
[PMID: 33289552]
|
|
PC-3
|
IC50 |
0.0183 μM
Compound: Triptolide
|
Cytotoxic activity against human PC3 cells assessed as reduction in cell viability after 72 hrs by SRB assay
Cytotoxic activity against human PC3 cells assessed as reduction in cell viability after 72 hrs by SRB assay
|
[PMID: 28011223]
|
|
PC-3
|
IC50 |
|
Cytotoxicity against human PC3 cells by SRB assay
Cytotoxicity against human PC3 cells by SRB assay
|
[PMID: 19637874]
|
|
PC-3
|
IC50 |
|
Antiproliferative activity against human PC3 cells after 72 hrs by SRB assay
Antiproliferative activity against human PC3 cells after 72 hrs by SRB assay
|
[PMID: 20833543]
|
|
PC-3
|
IC50 |
|
Cytotoxicity against human PC3 cells assessed as inhibition of cell proliferation by sulforhodamine B assay
Cytotoxicity against human PC3 cells assessed as inhibition of cell proliferation by sulforhodamine B assay
|
[PMID: 25467158]
|
|
PC-3
|
IC50 |
|
Cytotoxicity against human PC-3 cells assessed as inhibition of cell proliferation measured after 48 hrs by MTT assay
Cytotoxicity against human PC-3 cells assessed as inhibition of cell proliferation measured after 48 hrs by MTT assay
|
[PMID: 34700239]
|
|
PC-3
|
IC50 |
|
Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
Cytotoxicity against human PC3 cells after 72 hrs by MTT assay
|
[PMID: 19637874]
|
|
PC-3
|
IC50 |
|
Cytotoxicity against human PC3 cells after 72 hrs by sulforhodamine B assay
Cytotoxicity against human PC3 cells after 72 hrs by sulforhodamine B assay
|
[PMID: 24378709]
|
|
PC-3
|
IC50 |
|
Antiproliferative activity against human PC-3 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
Antiproliferative activity against human PC-3 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
|
[PMID: 35247754]
|
|
RAW264.7
|
IC50 |
|
Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha incubated for 1 hr followed by LPS stimulation and measured after 24 hrs by ELISA
Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha incubated for 1 hr followed by LPS stimulation and measured after 24 hrs by ELISA
|
[PMID: 32028140]
|
|
RAW264.7
|
IC50 |
|
Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced IL-6 incubated for 1 hr followed by LPS stimulation and measured after 24 hrs by ELISA
Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced IL-6 incubated for 1 hr followed by LPS stimulation and measured after 24 hrs by ELISA
|
[PMID: 32028140]
|
|
SGC-7901
|
IC50 |
|
Cytotoxicity against human SGC7901 cells after 72 hrs by MTT assay
Cytotoxicity against human SGC7901 cells after 72 hrs by MTT assay
|
[PMID: 19637874]
|
|
SJRH30
|
IC50 |
|
Cytotoxicity against human Rh30 cells after 72 hrs by MTT assay
Cytotoxicity against human Rh30 cells after 72 hrs by MTT assay
|
[PMID: 19637874]
|
|
SK-OV-3
|
IC50 |
|
Antiproliferative activity against human SKOV3 cells after 72 hrs by SRB assay
Antiproliferative activity against human SKOV3 cells after 72 hrs by SRB assay
|
[PMID: 20833543]
|
|
SK-OV-3
|
IC50 |
0.0072 μM
Compound: Triptolide
|
Cytotoxic activity against human SKOV3 cells assessed as reduction in cell viability after 72 hrs by SRB assay
Cytotoxic activity against human SKOV3 cells assessed as reduction in cell viability after 72 hrs by SRB assay
|
[PMID: 28011223]
|
|
SK-OV-3
|
IC50 |
|
Cytotoxicity against human SKOV3 cells by SRB assay
Cytotoxicity against human SKOV3 cells by SRB assay
|
[PMID: 19637874]
|
|
SK-OV-3
|
IC50 |
|
Cytotoxicity against human SKOV3 cells after 72 hrs by MTT assay
Cytotoxicity against human SKOV3 cells after 72 hrs by MTT assay
|
[PMID: 19637874]
|
|
SK-OV-3
|
IC50 |
|
Cytotoxicity against human SKOV3 cells after 72 hrs by sulforhodamine B assay
Cytotoxicity against human SKOV3 cells after 72 hrs by sulforhodamine B assay
|
[PMID: 24378709]
|
|
SK-OV-3
|
IC50 |
|
Cytotoxicity against human SK-OV-3 cells assessed as cell viability measured after 48 hrs by MTT assay
Cytotoxicity against human SK-OV-3 cells assessed as cell viability measured after 48 hrs by MTT assay
|
[PMID: 38964974]
|
|
SMMC-7721
|
IC50 |
|
Cytotoxicity against human SMMC7721 cells after 72 hrs by MTT assay
Cytotoxicity against human SMMC7721 cells after 72 hrs by MTT assay
|
[PMID: 19637874]
|
|
SW 1116
|
IC50 |
|
Cytotoxicity against human SW1116 cells after 72 hrs by MTT assay
Cytotoxicity against human SW1116 cells after 72 hrs by MTT assay
|
[PMID: 19637874]
|
|
SW-620
|
IC50 |
|
Cytotoxicity against human SW-620 cells incubated for 72 hrs by MTT assay
Cytotoxicity against human SW-620 cells incubated for 72 hrs by MTT assay
|
[PMID: 35617856]
|
|
SW480
|
IC50 |
|
Antiproliferative activity against human SW480 cells assessed as reduction in cell viability incubated for 24 hrs by CCK-8 assay
Antiproliferative activity against human SW480 cells assessed as reduction in cell viability incubated for 24 hrs by CCK-8 assay
|
[PMID: 33445154]
|
|
THP-1
|
IC50 |
|
Antiproliferative activity against human THP-1 cells assessed as inhibition of cell growth measured after 48 hrs by CCK8 assay
Antiproliferative activity against human THP-1 cells assessed as inhibition of cell growth measured after 48 hrs by CCK8 assay
|
[PMID: 36115206]
|
|
U-251
|
IC50 |
|
Cytotoxicity against human U251 cells assessed as inhibition of cell proliferation by sulforhodamine B assay
Cytotoxicity against human U251 cells assessed as inhibition of cell proliferation by sulforhodamine B assay
|
[PMID: 25467158]
|
|
U-251
|
IC50 |
|
Cytotoxicity against human U251 cells after 72 hrs by MTT assay
Cytotoxicity against human U251 cells after 72 hrs by MTT assay
|
[PMID: 19637874]
|